{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:58:55Z","timestamp":1790611135787,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100027026","name":"Johnson and Johnson Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12325-026-03693-2","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:05:10Z","timestamp":1783569910000},"page":"4529-4545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Racial and Ethnic Patterns Observed in Inflammatory Bowel Disease Prevalence, Clinical Burden, and Healthcare Resource Utilization in the United States: Findings from an Administrative Claims Database"],"prefix":"10.1007","volume":"43","author":[{"given":"Aarti A.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrlene","family":"Sanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7190-6323","authenticated-orcid":false,"given":"Sumesh","family":"Kachroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"1","key":"3693_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00384-024-04711-x","volume":"39","author":"D Lin","year":"1990","unstructured":"Lin D, Jin Y, Shao X, et al. Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021. Int J Colorectal Dis. 1990;39(1):139.","journal-title":"Int J Colorectal Dis"},{"key":"3693_CR2","unstructured":"Prevalence of inflammatory bowel disease among adults aged \u226518 years\u2014United States, 2015. [Internet]. Centers for Disease Control and Prevention 2015 [cited October 21, 2025]."},{"issue":"5","key":"3693_CR3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","volume":"165","author":"JD Lewis","year":"2023","unstructured":"Lewis JD, Parlett LE, Jonsson Funk ML, et al. Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology. 2023;165(5):1197-205.e2.","journal-title":"Gastroenterology"},{"key":"3693_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072482","author":"Z Tan","year":"2023","unstructured":"Tan Z, Zhu S, Liu C, et al. Causal link between inflammatory bowel disease and fistula: evidence from Mendelian randomization study. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12072482.","journal-title":"J Clin Med"},{"issue":"5","key":"3693_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S2468-1253(21)00014-5","volume":"6","author":"B Barberio","year":"2021","unstructured":"Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(5):359\u201370.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"13","key":"3693_CR6","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.3748\/wjg.v20.i13.3663","volume":"20","author":"W H\u00e4user","year":"2014","unstructured":"H\u00e4user W, Moser G, Klose P, Mikocka-Walus A. Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: a review. World J Gastroenterol. 2014;20(13):3663\u201371.","journal-title":"World J Gastroenterol"},{"key":"3693_CR7","doi-asserted-by":"publisher","first-page":"6496727","DOI":"10.1155\/2017\/6496727","volume":"2017","author":"G Byrne","year":"2017","unstructured":"Byrne G, Rosenfeld G, Leung Y, et al. Prevalence of anxiety and depression in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol. 2017;2017:6496727.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"3","key":"3693_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/j.gastro.2020.08.064","volume":"160","author":"EL Barnes","year":"2021","unstructured":"Barnes EL, Loftus EV Jr, Kappelman MD. Effects of race and ethnicity on diagnosis and management of inflammatory bowel diseases. Gastroenterology. 2021;160(3):677\u201389.","journal-title":"Gastroenterology"},{"issue":"10","key":"3693_CR9","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1038\/ajg.2010.202","volume":"105","author":"GC Nguyen","year":"2010","unstructured":"Nguyen GC, LaVeist TA, Harris ML, et al. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol. 2010;105(10):2202\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"3693_CR10","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1572-0241.2006.00504.x","volume":"101","author":"GC Nguyen","year":"2006","unstructured":"Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101(5):1012\u201323.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"3693_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12876-022-02560-y","volume":"22","author":"Q Cai","year":"2022","unstructured":"Cai Q, Ding Z, Fu AZ, Patel AA. Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies. BMC Gastroenterol. 2022;22(1):545.","journal-title":"BMC Gastroenterol"},{"key":"3693_CR12","unstructured":"Race and ethnicity data\u2014helping bridge the gap in health equity. 2024. https:\/\/www.optum.com\/en\/business\/insights\/advisory-services\/page.hub5.reporting-race-ethnicity-data-rwd.html."},{"issue":"10","key":"3693_CR13","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/ueg2.12350","volume":"10","author":"S Aniwan","year":"2022","unstructured":"Aniwan S, Santiago P, Loftus EV Jr, Park SH. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United Eur Gastroenterol J. 2022;10(10):1063\u201376.","journal-title":"United Eur Gastroenterol J"},{"issue":"2","key":"3693_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3349\/ymj.2021.62.2.99","volume":"62","author":"J Park","year":"2021","unstructured":"Park J, Cheon JH. Incidence and prevalence of inflammatory bowel disease across Asia. Yonsei Med J. 2021;62(2):99\u2013108.","journal-title":"Yonsei Med J"},{"issue":"5","key":"3693_CR15","first-page":"420","volume":"30","author":"Y Fan","year":"2024","unstructured":"Fan Y, Zhang L, Melmed GY. Prevalence, incidence, and treatment patterns of fistulizing Crohn disease: a US population-based cohort study. J Manag Care Spec Pharm. 2024;30(5):420\u20139.","journal-title":"J Manag Care Spec Pharm"},{"issue":"11","key":"3693_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrgastro.2017.104","volume":"14","author":"J Pan\u00e9s","year":"2017","unstructured":"Pan\u00e9s J, Rimola J. Perianal fistulizing Crohn\u2019s disease: pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol. 2017;14(11):652\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"3693_CR17","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/ibd\/izz056","volume":"25","author":"DA Schwartz","year":"2019","unstructured":"Schwartz DA, Tagarro I, Carmen D\u00edez M, Sandborn WJ. Prevalence of fistulizing Crohn\u2019s disease in the United States: estimate from a systematic literature review attempt and population-based database analysis. Inflamm Bowel Dis. 2019;25(11):1773\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"3693_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/ibd\/izad061","volume":"30","author":"Y Kilic","year":"2024","unstructured":"Kilic Y, Kamal S, Jaffar F, et al. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2024;30(2):230\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"3693_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/apt.17836","volume":"59","author":"L Gonczi","year":"2024","unstructured":"Gonczi L, Lakatos L, Golovics PA, et al. Burden of perianal disease in Crohn\u2019s disease: accelerating medical therapy and high rates of perianal surgery over the last four decades\u2014results from a population-based study over four decades. Aliment Pharmacol Ther. 2024;59(5):656\u201365.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"3693_CR20","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.14309\/ajg.0000000000002399","volume":"118","author":"L Bonfils","year":"2023","unstructured":"Bonfils L, Karachalia Sandri A, Poulsen GJ, et al. Medication-wide study: exploring medication use 10 years before a diagnosis of inflammatory bowel disease. Am J Gastroenterol. 2023;118(12):2220\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"3693_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s10620-022-07714-2","volume":"68","author":"NA Cohen","year":"2023","unstructured":"Cohen NA, Kliper E, Zamstein N, et al. Trends in biochemical parameters, healthcare resource and medication use in the 5 years preceding IBD diagnosis: a health maintenance organization cohort study. Dig Dis Sci. 2023;68(2):414\u201322.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"3693_CR22","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/ibd\/izab074","volume":"28","author":"S Singh","year":"1996","unstructured":"Singh S, Qian AS, Nguyen NH, et al. Trends in U.S. health care spending on inflammatory bowel diseases, 1996-2016. Inflamm Bowel Dis. 1996;28(3):364\u201372.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"3693_CR23","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/j.cgh.2020.01.023","volume":"18","author":"C Ma","year":"2020","unstructured":"Ma C, Smith MK, Guizzetti L, et al. Assessing national trends and disparities in ambulatory, emergency department, and inpatient visits for inflammatory bowel disease in the United States (2005\u20132016). Clin Gastroenterol Hepatol. 2020;18(11):2500-9.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"3693_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","volume":"114","author":"DT Rubin","year":"2019","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114(3):384\u2013413.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 3","key":"3693_CR25","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1\u2013106.","journal-title":"Gut"},{"issue":"10","key":"3693_CR26","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1038\/sj.bjc.6605359","volume":"101","author":"MW Lutgens","year":"2009","unstructured":"Lutgens MW, Oldenburg B, Siersema PD, et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer. 2009;101(10):1671\u20135.","journal-title":"Br J Cancer"},{"issue":"12","key":"3693_CR27","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1016\/j.cgh.2022.02.048","volume":"20","author":"HS Kim","year":"2022","unstructured":"Kim HS, Hernaez R, Sansgiry S, et al. Comparative effectiveness of surveillance colonoscopy intervals on colorectal cancer outcomes in a national cohort of patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2022;20(12):2848-57.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"3693_CR28","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.cgh.2024.04.039","volume":"22","author":"M Chavannes","year":"2024","unstructured":"Chavannes M, Dolinger MT, Cohen-Mekelburg S, Abraham B. AGA clinical practice update on the role of intestinal ultrasound in inflammatory bowel disease: commentary. Clin Gastroenterol Hepatol. 2024;22(9):1790-5.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"14","key":"3693_CR29","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.3390\/jcm14144817","volume":"14","author":"G Bilican","year":"2025","unstructured":"Bilican G, Karakan T, E\u011frita\u015f G\u00fcrkan \u00d6, et al. Intestinal ultrasound: advancing towards broader adoption\u2014insights from a national survey in Turkey. J Clin Med. 2025;14(14):4817.","journal-title":"J Clin Med"},{"issue":"7","key":"3693_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/ibd.20873","volume":"15","author":"LA Graff","year":"2009","unstructured":"Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009;15(7):1105\u201318.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03693-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03693-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03693-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:39:32Z","timestamp":1790609972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03693-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3693"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03693-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Aarti A. Patel, Myrlene Sanon, and Sumesh Kachroo: Employees of Johnson & Johnson and may hold stock or stock options from Johnson & Johnson. Shannon Ferrante: Former employee of Johnson & Johnson and may hold stock or stock options from Johnson & Johnson\n                      .\n                      Current affiliation: Kyowa Kirin, Inc., Princeton, New Jersey, USA.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All included data were collected anonymously using techniques compliant with the Health Insurance Portability and Accountability Act of 1996. No patient identification data were used, and de\u2011identified claims were accessed under license therefore, this study did not meet the requirements for informed consent and Institutional Review Board (IRB) approval.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}